Evidence map›Paper›PMID 36998300›Full record

ReviewAnnals of gastroenterological surgery2023

Essential updates 2020/2021: Advancing precision medicine for comprehensive rectal cancer treatment.

Ichiro Takemasa, Atsushi Hamabe, Masaaki Miyo, Emi Akizuki, Koichi Okuya

Full text readReview
In one paragraph

Review in Annals of gastroenterological surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Article
  5. Diagnosis and Treatment of Low Anterior Resection Syndrome.Journal of the anus, rectum and colon · 2025
    Review
  6. Article
  7. Questionnaire to Survey Cosmetic Outcomes in Laparoscopic Surgery for Colorectal Cancer.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Novel and classic approaches for managing gastrointestinal cancers.Annals of gastroenterological surgery · 2023
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ichiro TakemasaDepartment of Surgery, Surgical Oncology and Science Sapporo Medical University Sapporo Japan.ORCID https://orcid.org/0000-0003-1595-2453
Atsushi HamabeDepartment of Surgery, Surgical Oncology and Science Sapporo Medical University Sapporo Japan.ORCID https://orcid.org/0000-0001-5535-3514
Masaaki MiyoDepartment of Surgery, Surgical Oncology and Science Sapporo Medical University Sapporo Japan.
Emi AkizukiDepartment of Surgery, Surgical Oncology and Science Sapporo Medical University Sapporo Japan.
Koichi OkuyaDepartment of Surgery, Surgical Oncology and Science Sapporo Medical University Sapporo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the paradigm shift related to rectal cancer treatment, we have to understand a variety of new emerging topics to provide appropriate treatment for individual patients as precision medicine. However, information on surgery, genomic medicine, and pharmacotherapy is highly specialized and subdivided, creating a barrier to achieving thorough knowledge. In this review, we summarize the perspective for rectal cancer treatment and management from the current standard-of-care to the latest findings to help optimize treatment strategy.

Indexed as

diagnosismultimodal therapyrectal cancerstratificationsurgery

Identifiers

PMID36998300
PMCPMC10043777

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read103
identifiers read4
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.